These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14664197)

  • 1. The use of erythropoietin.
    Langston CE; Reine NJ; Kittrell D
    Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1245-60. PubMed ID: 14664197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant erythropoietin used to treat a cat with anemia caused by chronic renal failure.
    Henry PA
    Can Vet J; 1994 Jun; 35(6):375. PubMed ID: 8069840
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoietin treatment for non-uremic patients: a personal view.
    Biesma DH
    Neth J Med; 1999 Jan; 54(1):10-5. PubMed ID: 10048290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.
    Kabaya K; Akiyama H; Nishi N; Misaizu T; Okada Y; Kawagishi M; Amano K; Kusaka M; Seki M; Uzumaki H
    Life Sci; 1995; 57(11):1067-76. PubMed ID: 7658914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin.
    Randolph JE; Scarlett JM; Stokol T; Saunders KM; MacLeod JN
    Am J Vet Res; 2004 Oct; 65(10):1355-66. PubMed ID: 15524322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum erythropoietin concentrations measured by radioimmunoassay in normal, polycythemic, and anemic dogs and cats.
    Cook SM; Lothrop CD
    J Vet Intern Med; 1994; 8(1):18-25. PubMed ID: 8176658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoproliferative anemias and anemias caused by ineffective erythropoiesis. Depression or nonresponsive anemias.
    Feldman BF
    Vet Clin North Am Small Anim Pract; 1981 May; 11(2):277-88. PubMed ID: 7032047
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.
    Chalhoub S; Langston CE; Farrelly J
    J Vet Intern Med; 2012; 26(2):363-9. PubMed ID: 22296687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic basis for the pharmacologic use of recombinant human erythropoietin in surgery and cancer treatment.
    Adamson JW; Spivak JL
    Surgery; 1994 Jan; 115(1):7-15. PubMed ID: 8284765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology and management of anemia in chronic progressive renal failure.
    Cowgill LD
    Semin Vet Med Surg Small Anim; 1992 Aug; 7(3):175-82. PubMed ID: 1410849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.
    Arai M; Darman J; Lewis A; Yamamoto JK
    Vet Immunol Immunopathol; 2000 Nov; 77(1-2):71-92. PubMed ID: 11068067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma erythropoietin concentrations in dogs and cats: reference values and changes with anaemia and/or chronic renal failure.
    Pechereau D; Martel P; Braun JP
    Res Vet Sci; 1997; 62(2):185-8. PubMed ID: 9243721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
    Garrido P; Ribeiro S; Fernandes J; Vala H; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Santos-Silva A; Reis F
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and the anemia of cancer.
    Beguin Y
    Acta Clin Belg; 1996; 51(1):36-52. PubMed ID: 8669161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
    Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
    Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
    Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.